1st Ebola vaccine clinical study in Japan to begin this month english.kyodonews.net

The researchers said they aim to develop the Ebola vaccine to prevent further outbreaks of the deadly hemorrhagic fever in Africa.
Kawaoka developed the new vaccine using an inactivated Ebola virus that cannot replicate in normal cells.
Although possession of the Ebola virus is strictly regulated in Japan, artificially produced viruses are not.
Two major American pharmaceutical companies have also developed Ebola vaccines, with vaccinations under way on the African continent.
The Ebola virus is transmitted through direct contact with body fluids, such as the blood and excrement of infected people.